Mark J. Canet
Denali Therapeutics (United States)(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Drug Transport and Resistance Mechanisms, Liver Diseases and Immunity, Diet, Metabolism, and Disease, Liver physiology and pathology
Most-Cited Works
- → Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease(2010)195 cited
- → Variations in ATP-Binding Cassette Transporter Regulation during the Progression of Human Nonalcoholic Fatty Liver Disease(2011)138 cited
- → Altered Regulation of Hepatic Efflux Transporters Disrupts Acetaminophen Disposition in Pediatric Nonalcoholic Steatohepatitis(2015)68 cited
- → Modeling Human Nonalcoholic Steatohepatitis-Associated Changes in Drug Transporter Expression Using Experimental Rodent Models(2014)67 cited
- → Molecular Mechanism of Altered Ezetimibe Disposition in Nonalcoholic Steatohepatitis(2011)67 cited
- → Increased Susceptibility to Methotrexate-Induced Toxicity in Nonalcoholic Steatohepatitis(2014)61 cited
- → Experimental Nonalcoholic Steatohepatitis Increases Exposure to Simvastatin Hydroxy Acid by Decreasing Hepatic Organic Anion Transporting Polypeptide Expression(2014)47 cited
- → Hepatic NF-kB-inducing kinase (NIK) suppresses mouse liver regeneration in acute and chronic liver diseases(2018)37 cited
- → Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity(2015)35 cited
- → Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis(2017)32 cited